This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2004-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2005
Title: Horst Blum: Innovator in Imidazolidine Derivatives
Introduction
Horst Blum is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his work on imidazolidine derivatives. With a total of 2 patents to his name, Blum's innovations have the potential to impact various therapeutic applications.
Latest Patents
Blum's latest patents include "Imidazolidine derivatives, their preparation and their use" and "Imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them." These patents focus on novel imidazolidine derivatives, detailing their chemical formulations and potential applications in medicine.
Career Highlights
Horst Blum is currently associated with Aventis Pharma Deutschland GmbH, where he continues to advance his research and development efforts. His work at this prominent pharmaceutical company has allowed him to explore innovative solutions in drug development.
Collaborations
Throughout his career, Blum has collaborated with esteemed colleagues such as Volkmar Wehner and Hans Ulrich Stilz. These partnerships have fostered a collaborative environment that enhances the quality and scope of their research.
Conclusion
Horst Blum's contributions to the field of pharmaceuticals, particularly through his patents on imidazolidine derivatives, highlight his role as an influential inventor. His ongoing work at Aventis Pharma Deutschland GmbH continues to pave the way for future innovations in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile